Traditional Chinese medicine decoction for treating ulcerative colitis

Abstract

A disclosed traditional Chinese medicine decoction for treating ulcerative colitis is composed of the raw materials in parts by weight: 10-12 parts of radix astragali, 2-3 parts of rhizoma atractylodis, 5-7 parts of herba agrimoniae, 5-7 parts of radix bupleuri, 3-4 parts of radix morindae officinalis, 2-4 parts of prepared radix et rhizoma rhei, 6-8 parts of portulaca oleracea, 10-12 parts of leaf of leatherleaf mahonia, 3-5 parts of hyacinth dolichos shell, 10-12 parts of fructus lycii, 3-5 parts of indigo naturalis, 2-4 parts of radix linderae, 5-7 parts of herba taraxaci, 20-25 parts of plumula nelumbinis, 3-5 parts of semen plantaginis, 2-4 parts of radix scrophulariae, 1-3 parts of rhizoma acori tatarinowii, 2-4 parts of howthorn seed, 5-6 parts of radix saposhnikoviae, 3-5 parts of scoparia dulcis, 2-4 parts of common dysosmatis rhizome and root, 1-3 parts of euphorbia hirta, 2-4 parts of root of griffith streptocaulon and 1-3 parts of caesalpinia minax Hance.. Through scientific compatibility and mutual supplement of compositions, the traditional Chinese medicine has the efficacy of soothing liver and tonifying kidney, resolving dampness and moistening dryness, engendering fluid and moistening intestines, and warming spleen and checking diarrhea, and is substantial in treatment effect, reliable in effects and free of any toxic and side effects for treating ulcerative colitis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction for treating ulcerative colitis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Ulcerative colitis is a serious chronic disease with lesions confined to the mucosa and submucosa of the large intestine. The lesions are mostly located in the sigmoid colon and rectum, and can also extend to the descending colon, or even the entire colon. The course of the disease is long, long-term medication is required, the prognosis is poor, and hospitalization or surgical treatment is required if necessary; the disease occurs at any age, but it is most common in 20-30 years old, which seriously affects the quality of life of patients and increases the mental pressure and economic burden of patients. Contents of the invention [0003] The object of the present invention is to provide a Chinese medicine decoction for treating ulcerative colitis. [0004]...

AI Technical Summary

Problems solved by technology

The course of the disease is long, long-term medication is required, the prognosis is poor, and hospitalization or surgical treatment is required if necessary; the disease occurs at any age, but it is most common in 20-30 years old, which seriously affects the quality of life of patients and increases the mental pressure and economic burden of patients